Laboratory of Clinical Immunology, National Institutes of Allergy and Infectious Disease, The National Institutes of Health, Bethesda, Maryland, USA.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Immunol Rev. 2024 Mar;322(1):71-80. doi: 10.1111/imr.13308. Epub 2024 Mar 1.
Since their description by Metchnikoff in 1905, phagocytes have been increasingly recognized to be the entities that traffic to sites of infection and inflammation, engulf and kill infecting organisms, and clear out apoptotic debris all the while making antigens available and accessible to the lymphoid organs for future use. Therefore, phagocytes provide the gateway and the first check in host protection and immune response. Disorders in killing and chemotaxis lead not only to infection susceptibility, but also to autoimmunity. We aim to describe chronic granulomatous disease and the leukocyte adhesion deficiencies as well as myeloperoxidase deficiency and G6PD deficiency as paradigms of critical pathways.
自 1905 年梅契尼科夫(Metchnikoff)描述以来,吞噬细胞逐渐被认识到是能够迁移到感染和炎症部位、吞噬和杀死感染病原体,并清除凋亡碎片的实体,同时使抗原能够提供给淋巴器官以供未来使用。因此,吞噬细胞为宿主保护和免疫反应提供了入口和第一道防线。吞噬细胞的杀伤和趋化作用障碍不仅导致易感性感染,还导致自身免疫。我们旨在描述慢性肉芽肿病和白细胞黏附缺陷症以及髓过氧化物酶缺乏症和 G6PD 缺乏症作为关键途径的范例。